Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,066 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Idiopathic dendriform pulmonary ossification as the phenotype of interstitial lung abnormalities: CT-pathologic correlation and prevalence.
Ueno M, Egashira R, Hashisako M, Fujimoto K, Fukuda T, Hayashida Y, Sumikawa H, Tominaga J, Tanaka T, Terasaki Y, Fukuoka J, Nishioka Y, Aoki T, Gabata T, Hatabu H, Johkoh T. Ueno M, et al. Among authors: fujimoto k. Jpn J Radiol. 2024 May 14. doi: 10.1007/s11604-024-01590-8. Online ahead of print. Jpn J Radiol. 2024. PMID: 38740642
Integrated Electronic Health Record of Multidisciplinary Professionals Throughout the Cancer Care Pathway: A Pilot Study Exploring Patient-Centered Information in Breast Cancer Patients.
Sugiyama A, Okumiya H, Fujimoto K, Utsunomiya K, Shimomura Y, Sanuki M, Kume K, Yano T, Kagawa R, Bando H. Sugiyama A, et al. Among authors: fujimoto k. J Multidiscip Healthc. 2024 May 7;17:2069-2081. doi: 10.2147/JMDH.S455281. eCollection 2024. J Multidiscip Healthc. 2024. PMID: 38736534 Free PMC article.
Efficacy of a hydrogel spacer for improving quality of life in patients with prostate cancer undergoing low-dose-rate brachytherapy alone or in combination with intensity-modulated radiotherapy: An observational study using propensity score matching.
Nakai Y, Tanaka N, Asakawa I, Ohnishi K, Miyake M, Yamaki K, Torimoto K, Fujimoto K. Nakai Y, et al. Among authors: fujimoto k. Prostate. 2024 May 12. doi: 10.1002/pros.24744. Online ahead of print. Prostate. 2024. PMID: 38734992
J-AVENUE: A retrospective, real-world study evaluating patient characteristics and outcomes in patients with advanced urothelial carcinoma treated with avelumab first-line maintenance therapy in Japan.
Kikuchi E, Hayakawa N, Nakayama M, Uno M, Nakatsu H, Kitagawa C, Miyake H, Yamada T, Fujita K, Shimoyama H, Nishihara K, Kobayashi M, Nakamura M, Fujimoto K, Sano T, Nishiyama N, Ito T, Kajita M, Kobayashi T, Kitamura H. Kikuchi E, et al. Among authors: fujimoto k. Int J Urol. 2024 May 9. doi: 10.1111/iju.15473. Online ahead of print. Int J Urol. 2024. PMID: 38722221
In vitro and in vivo activities of KSP-1007, a broad-spectrum inhibitor of serine- and metallo-β-lactamases, in combination with meropenem against carbapenem-resistant Gram-negative bacteria.
Takemoto K, Nakayama R, Fujimoto K, Suzuki Y, Takarabe Y, Honsho M, Kitahara S, Noguchi Y, Matsui H, Hirose T, Asami Y, Hidaka J, Sunazuka T, Hanaki H. Takemoto K, et al. Among authors: fujimoto k. Antimicrob Agents Chemother. 2024 May 6:e0160223. doi: 10.1128/aac.01602-23. Online ahead of print. Antimicrob Agents Chemother. 2024. PMID: 38709005 Free article.
4,066 results